The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Primaquine Therapy for Malaria
Abstract
Primaquine is the only available drug for preventing relapse of malaria, and confusion surrounds its use. This review examines the wide range of clinical applications of primaquine described in the medical literature between 1946 and 2004. The risk of relapse of Plasmodium vivax malaria without primaquine therapy ranged from 5% to 80% or more, depending largely upon geographic location. Supervision of therapy profoundly impacts the risk of relapse, and almost all reports of malaria resistant to primaquine are associated with lack of such supervision. We nonetheless suspect that there is widespread resistance to the standard course of primaquine therapy, which is 15 mg primaquine base daily for 14 days. Clinical evidence confirms that a course of 15 mg daily for just 5 days, a regimen widely used in areas where malaria is endemic, has no discernible efficacy. This review supports a recommendation for a regimen of 0.5 mg/kg primaquine daily for 14 days, on the basis of superior efficacy and good tolerability and safety in nonpregnant persons without glucose-6-phosphate dehydrogenase deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
The Journal of Laboratory and Clinical Medicine
(2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00127-6 · Cited by 1,767
Indian Journal of Medical Research
(2024) · The Indian Journal of Medical Research · doi:10.25259/ijmr · Cited by 1,740
British Journal of Pharmacology
(2010) · British Journal of Pharmacology · doi:10.1111/(issn)1476-5381 · Cited by 920
Beutler, E. (1994) · Blood · doi:10.1182/blood.v84.11.3613.bloodjournal84113613 · Cited by 731
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Rieckmann, K. H., Davis, D. R., & Hutton, D. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91792-3 · Cited by 501
Coatney, G. R., Collins, W. E., Warren, M., & Contacos, P. G. (1971) · Cited by 454
Drug-Induced Methaemoglobinaemia Treatment Issues
Coleman, M. D., & Coleman, N. A. (1996) · Drug Safety · doi:10.2165/00002018-199614060-00005 · Cited by 275
Resistance to Chloroquine by Plasmodium vivax in Irian Jaya, Indonesia
Baird, J. K., Basri, H., Purnomo, Bangs, M. J., Subianto, B., Patchen, L. C., & Hoffman, S. L. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.44.547 · Cited by 232
Self-citationCompliance With Topical Timolol Treatment
Kass, M. A., Gordon, M., Morley, R. E., Meltzer, D. W., & Goldberg, J. J. (1987) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74225-4 · Cited by 212
Vivax malaria resistant to treatment and prophylaxis with chloroquine
Murphy, G. S., Basri, H., Andersen, E. M., Bangs, M. J., Gorden, J., Sorensen, K., Mount, D. L., Lal, A. A., Purwokusumo, A. R., Harjosuwarno, S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92568-e · Cited by 209
Self-citationDelayed Onset of Malaria — Implications for Chemoprophylaxis in Travelers
Schwartz, E., Parise, M. E., Kozarsky, P. E., & Cetron, M. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021592 · Cited by 185
Baird, J. K., Leksana, B., Masbar, S., Fryauff, D. J., Sutanihardja, M. A., Suradi, Wignall, F. S., & Hoffman, S. L. (1997) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1997.56.621 · Cited by 171
Self-citationRisk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings
Sawaya, G. F., McConnell, K. J., Kulasingam, S. L., Lawson, H. W., Kerlikowske, K., Melnikow, J., Lee, N. C., Gildengorin, G., Myers, E. R., & Washington, A. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035419 · Cited by 170
Primaquine Resistance in Plasmodium vivax
Collins, W. E., & Jeffery, G. M. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.243 · Cited by 158
Antimalarial Chemotherapy. Mechanisms of Action, Resistance and New Directions in Drug Discovery
(2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg183 · Cited by 157
Tropical and Geographical Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_6 · Cited by 155
Zucker, J. R. (1996) · Emerging infectious diseases · doi:10.3201/eid0201.960104 · Cited by 154
Phillips, E. J., Keystone, J. S., & Kain, K. C. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.1171 · Cited by 152
Alving, A. S., JOHNSON, C. F., Tarlov, A. R., Brewer, G. J., Kellermeyer, R. W., & Carson, P. E. (1960) · Europe PMC (PubMed Central) · Cited by 144
Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen
Roth, H. P., & Caron, H. S. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978233361 · Cited by 138
Blood Stage Antimalarial Efficacy of Primaquine in Plasmodium vivax Malaria
Pukrittayakamee, S., Vanijanonta, S., Chantra, A., Clemens, R. L., & White, N. J. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.4.932 · Cited by 122
Treatment of Chloroquine-Resistant Plasmodium vivax with Chloroquine and Primaquine or Halofantrine
Baird, J. K., Basri, H., Subianto, B., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1678 · Cited by 115
Self-citationHøgh, B., Gamage-Mendis, A. C., Butcher, G. A., Thompson, R. C. A., Begtrup, K., Mendis, C., Enosse, S. M., Dgedge, M., Barreto, J. D., Eling, W. M. C., et al. (1998) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1998.58.176 · Cited by 107
Resurgent Malaria at the Millennium
Baird, J. K. (2000) · Drugs · doi:10.2165/00003495-200059040-00001 · Cited by 87
Self-citationRieckmann, K. H., McNamara, J. V., Frischer, H., Stockert, T. A., Carson, P. E., & Powell, R. D. (1968) · Europe PMC (PubMed Central) · Cited by 85
Radical Cure of Infections with Plasmodium cynomolgi: a Function of Total 8-Aminoquinoline Dose
Schmidt, L. H., Fradkin, R., Vaughan, D., & Rasco, J. F. (1977) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1977.26.1116 · Cited by 74
Treatment of vivax malaria on the western border of Thailand
Luxemburger, C., van Vugt, M., Jonathan, S., McGready, R. M., Looareesuwan, S., White, N. J., & Nosten, F. H. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90149-9 · Cited by 71
Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
Wilairatana, P., Silachamroon, U., Krudsood, S., Singhasivanon, P., Treeprasertsuk, S., Bussaratid, V., Phumratanaprapin, W., Srivilirit, S., & Looareesuwan, S. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.973 · Cited by 49
Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy.
Arias, A. E., & Corredor, A. (1989) · PubMed · Cited by 48
Induced primaquine resistance in vivax malaria
Arnold, J. D., Alving, A. S., Clayman, C. Β., & Hochwald, R. S. (1961) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(61)90103-1 · Cited by 42
Field trials of a rapid test for G6PD deficiency in combination with a rapid diagnosis of malaria
Tantular, I. S., Iwai, K., Lin, K., Basuki, S., Horie, T., Htay, H., Matsuoka, H., Marwoto, H., Wongsrichanalai, C., Dachlan, Y. P., et al. (1999) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1999.00395.x · Cited by 40
Martelo, O. J., Smoller, M., & Saladin, T. A. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.123.4.383 · Cited by 39
Baird, J. K., Wiady, I., Sutanihardja, A., Suradi, S., Purnomo, P., Basri, H., Sekartuti, Ayomi, E., Fryauff, D. J., & Hoffman, S. L. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.66.659 · Cited by 27
Self-citationSwellengrebel lecture. Hypnozoites and 'relapses' in Plasmodium vivax and in vivax-like malaria.
Garnhám, P. C. C. (1988) · PubMed · Cited by 26
Malaria in a Nonimmune Population after Extended Chloroquine or Primaquine Prophylaxis
Fryauff, D. J., Baird, J. K., Purnomo, P., Awalludin, M., Jones, T. R., Subianto, B., Richie, T. L., Tjitra, E., Wignall, F. S., & Hoffman, S. L. (1997) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1997.56.137 · Cited by 21
Self-citationKlein, T. A., Tada, M. S., Lima, J. B. P., & Katsuragawa, T. H. (1991) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.45.471 · Cited by 21
Dua, V. K., & Sharma, A. (2001) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034980120103225 · Cited by 13
Nathwani, D., Currie, P. F., Smith, C., & Khaund, R. R. (1991) · Journal of Infection · doi:10.1016/0163-4453(91)93548-q · Cited by 11
Normal immunological responses in mice treated with chloroquine, quinine and primaquine
Thong, Y. H., Ferrante, A., & Secker, L. K. (1981) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(81)90021-3 · Cited by 7
Polyresistant Malaria in Gurkha Soldiers Returning from Papua New Guinea: Treatment and Prevention
Henderson, A., Simon, J., Melia, W. M., et al. (1986) · Journal of the Royal Army Medical Corps · doi:10.1136/jramc-132-01-09 · Cited by 7
Antirelapse treatment with primaquine and pyrimethamine.
Singh, J., Ray, A. P., Misra, B. G., et al. (1954) · PubMed · Cited by 5
Cited by
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
Carlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E., Crabtree, J., Angiuoli, S. V., Merino, E. F., Amedeo, P., et al. (2008) · Nature · doi:10.1038/nature07327 · Cited by 835
Self-citationKey gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Mueller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & del Portillo, H. A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70177-x · Cited by 661
Self-citationTjitra, E., Anstey, N. M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D. A., & Price, R. N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050128 · Cited by 611
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398
Self-citation
Metadata
- Authors
- Baird, J. K., & Hoffman, S. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-01
- Volume
- 39
- Issue
- 9
- Pages
- 1336-1345
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2158149195
- Cited by
- 435
- References
- 42
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.